Extract of Prunella vulgaris spikes inhibits HIV replication at reverse transcription in vitro and can be absorbed from intestine in vivo

Antiviral Chemistry and Chemotherapy

Volumn 11, Issue 2, 2000, Pages 157-164

  Kageyama, Seiji ^a   Kurokawa, Masahiko ^a   Shiraki, Kimiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

HIV; Intestinal absorption; Prunella spike; Prunella vulgaris; Reverse transcriptase

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DEXTRAN SULFATE; DIDANOSINE; PLANT EXTRACT; PRUNELLA VULGARIS EXTRACT; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; GIANT CELL; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS REPLICATION;

EID: 0034096463     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020001100207     Document Type: Article

References (26)

1. Baba M, Pauwels R, Balzarini J, Arnout J, Desmyter J, & De Clercq E (1988) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proceedings of the National Academy of Sciences, USA 85:6132-6136.
2. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, & Volberding PA (1998) Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. Journal of the American Medical Association 280:78-86.
3. Chang RS & Yeung HW (1988) Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs. Antiviral Research 9:163-175.
4. De Clercq E (1998) The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection. Antiviral Research 38:153-179.
5. Dixon M & Webb E (1979) Enzyme inhibition and activation. In Enzyme, 3rd edition, p.p. 332-467 Edited by M Dixon, E Webb, C Thorne & K Tipton. London: Longman Group Ltd.
6. Hartman NR, Johns DG & Mitsuya H (1990) Pharmacokinetic analysis of dextran sulfate in rats as pertains to its clinical usefulness for therapy of HIV infection. AIDS Research and Human Retroviruses 6:805-812.
7. Hogg RS, O'Shaughnessy MV, Gataric N, Yip B, Craib K, Schechter MT & Montaner JS (1997) Decline in deaths from AIDS due to new antiretrovirals. Lancet 349:1294.
8. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT & Montaner JS (1998) Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. Journal of the American Medical Association 279:450-454.
9. Kageyama S, Weinstein JN, Shirasaka T, Kempf DJ, Norbeck DW, Plattner JJ, Erickson J & Mitsuya H (1992). In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations. Antimicrobial Agents and Chemotherapy 36:926-933.
10. Kojima J & Ogura H (1986) Triterpenoids from Prunella vulgaris. Phytochemistry 25:729-733.
11. Kurokawa M, Hozumi T, Basnet P, Nakano M, Kadota S, Namba T, Kawana T & Shiraki K (1998) Purification and characterization of eugeniin as an anti-herpesvirus compound from Geum japonicum and Syzygium aromaticum. Journal of Pharmology and Experimental Therapeutics 284:728-735.
12. Menzo S, Bagnarelli P, Giacca M, Manzin A, Varaldo PE & Clementi M (1992). Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. Journal of Clinical Microbiology 30:1752-1757.
13. Mitsuya H & Broder S (1986) Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proceedings of the National Academy of Sciences, USA 83:1911-1915.
14. Mitsuya H, Looney DJ, Kuno S, Ueno R, Wong-Staal F & Broder S (1988). Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells. Science 240:646-649.
15. Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ & Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine 338:853-860.
16. Piatak M, Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM & Lifson JD (1993) High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
17. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD & Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences, USA 77:7415-7419.
18. Senior K (1996) Pharmaceuticals from plants: promises and progress. Molecular Medicine Today 2:60-64.
19. Tabba HD, Chang RS & Smith KM (1989) Isolation, purification, and partial characterization of prunellin, an anti-HIV component from aqueous extracts of Prunella vulgaris. Antiviral Research 11:263-273.
20. Taniguchi K, Tsuchie H, Kageyama S, Iwasaki M, Takagi T, Sasao F, Ueda S & Kurimura T (1998) Slight difference in primary amino acid sequence of p17 matrix protein of HIV-1 exerts profound influence on its antigenicity. Archives of Virology 143:881-890.
21. Ueno T, Shirasaka T & Mitsuya H (1995) Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2′,3′-dideoxynucleoside 5′-triphosphates. Journal of Biological Chemistry 270:23605-23611.
22. Wolfe SL (1993) Molecular and cellular biology. Wadsworth, Inc., Belmont.
23. Yamasaki K, Nakano M, Kawahata T, Mori H, Otake T, Ueba N, Oishi I, Inami R, Yamane M, Nakamura M, Murata H & Nakanishi T (1998) Anti-HIV-1 activity of herbs in Labiatae. Biological & Pharmacological Bulletin 21:829-833.
24. Yao XJ, Wainberg MA & Parniak MA (1992) Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris. Virology 187:56-62.
25. Yukawa TA, Kurokawa M, Sato H, Yoshida Y, Kageyama S, Hasegawa T, Namba T, Imakita M, Hozumi T & Shiraki K (1996) Prophylactic treatment of cytomegalovirus infection with traditional herbs. Antiviral Research 32:63-70.
26. Zazzi M, Romano L, Brasini A & Valensin PE (1992) Nested polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in clinical specimens. Journal of Medical Virology 38:172-174.